INSIGHTS ON DRUG DEVELOPMENT

• Integrating Phase-Appropriate Quality Standards

  Incorporating phase-specific quality standards ensures GMP compliance. Collaborating with an experienced CDMO addresses late-stage quality needs and efficiently manages development timelines.

• Next-Gen Disease Models And Cell Therapeutics: Innovations In AI, Omics And Collaboration

  Learn how to leverage AI, omics integration, and collaborative research to build more physiologically relevant disease models and accelerate the development of next-gen cell therapies.

• Automated Bioburden Testing Solution

  Automation is transforming microbial quality control labs, boosting productivity, minimizing errors, and ensuring data integrity. Discover how digitalization is driving Pharma 4.0 and reshaping lab workflows.

• Introducing 2 New Highly Effective ADC Payloads For Cancer Therapeutics

  Unlock the potential of antibody-drug conjugates (ADCs) by exploring our novel payloads, designed for easy access and evaluation, to accelerate your ADC drug development with proven efficacy and safety.

• Achieving Optimal CAR-T Cell Generation

  10/9/2024

  Discover the innovative methods behind CAR-T cell production, from custom plasmid design to lentiviral vector transduction, and explore their potential in revolutionizing cancer treatment.

• Futurizing Healthcare By Localizing The Life Sciences

  12/12/2024

  Mustapha Bittaye's journey highlights the importance of international funding in fostering local scientific talent and biopharma resilience, empowering research and manufacturing in developing countries.

• Measuring Thermodynamic Parameters In The Drug Development Process

  4/29/2025

  Join Dr. Ladbury to explore how thermodynamic data can enhance our understanding of protein-ligand interactions and how it is crucial for optimizing drug efficacy and safety in pharmaceutical development.

• Multifactorial Disease Models: De-Risking Topical Formulation Development

  10/20/2025

  Traditional drug models fail to predict performance in human skin. Advanced, multifactorial ex vivo disease models directly address inflammation and infection to de-risk formulation development.

• Functional Characterization Of 3D Assembled Neurospheres

  4/4/2025

  Neural organoids and 3D spheroids offer advanced platforms for brain research and drug discovery. Discover how creating 3D neurospheres from iPSC-derived neurons and astrocytes aids in compound profiling and toxicity testing.